Founders

Regina Elena Institute (IRE)


INSTITUTE

Regina Elena Institute (IRE)

ADDRESS

Via Elio Chianesi, 53 - 00144 Roma

FOUNDED

1933

FIELD

Oncology

PHONE

06 52662728

EMAIL

dirscire@ifo.gov.it

WEB

www.ifo.it

SOCIAL NETWORKS
SCIENTIFIC DIRECTOR

Prof. Gennaro Ciliberto


Regina Elena Institute (IRE) was established in 1933, is one of the largest and renowned cancer research centers in Europe. Moreover, the research facilities of the Institute represent one of the most technologically advanced laboratories in Europe to support the Institutes’ diagnostic, preventive, therapeutic, predictive and prognostic approach.

Both the clinical and research activities and projects carried on by the IRCCS are financed by the Ministry of Health, the Lazio Region and other public and private Institutions, either national and international.

IRE recognizes the importance to create a network of collaborations with other national and international centers of excellence. The institute is a member of several international research organizations, as the Union for International Cancer Control (UICC), and the European Organization for Research and Treatment of Cancer (EORTC- Early Clinical Trial Group. Moreover, the Institute hosts in its facilities the Rome Oncogenomic Center, one of the four Italian technological platforms founded by the Italian Association for Cancer Research (AIRC). In September 2015 the European Organization of Cancer Institutes (OECI) certificated and designed the IRE  Cancer Center  as a comprehensive Cancer Center, one of the only 13 institutes certificated in the Europe.

IRE is the forefront of public health. With its particular emphasis on cancer prevention programmes the Institute gives a major cultural contribution to  Regional health policies. Strategic relationships with the Regional Government and the National Ministry of Health make the Institute able to fulfil the role of an Oncologic Center for Regional Coordination. A ”Center Hub” capable to offer a best quality service to meet the population’s expectation and needs.

One of the Institute’s priorities is the treatment of breast cancers.  Our interdipartimental approach (several specialists belonging to different departments work together to develop a diagnostic-therapeutic strategy) offers a better service to the patients, optimizing and integrating prevention, early diagnosis and therapy.